<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01744483</url>
  </required_header>
  <id_info>
    <org_study_id>42230</org_study_id>
    <secondary_id>5R34HL105581-02</secondary_id>
    <nct_id>NCT01744483</nct_id>
  </id_info>
  <brief_title>Endotracheal Tubes for Prevention of Ventilator-associated Pneumonia</brief_title>
  <acronym>PreVent</acronym>
  <official_title>Pilot Trial of Tubes to Prevent Ventilator-Associated Pneumonia (PreVent)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are looking at three different types of breathing tubes to see if any of them are
      better at preventing pneumonia than the others. Two of the tubes have design features to
      prevent leakage of fluids from the mouth and throat into the lungs. This is importance, since
      leakage of small amounts of fluid into the lungs may lead to pneumonia. The third tube is the
      standard tube used at most hospitals.

      The hypothesis is that the use of a breathing tube that reduces fluid leakage into the lungs
      will reduce the risk of developing pneumonia, compared to the standard tube. The study will
      also look at the safety of the modified breathing tubes, compared to the standard tube.

      This study is a small, &quot;pilot&quot; study that will determine if it is possible to perform a
      larger study that will provide more certain results.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this pilot study is provide data for planning and to establish the
      feasibility of performing a large, randomized, comparative effectiveness trial of two
      specially designed airway tubes (endotracheal tubes; ETTs) for the prevention of
      ventilator-associated pneumonia (VAP). Modification of the material and design of the ETT
      cuff that is positioned in the trachea, and/or continuous aspiration of subglottic secretions
      through an extra port positioned between the tube cuff and the vocal chords may prevent
      leakage of contaminated secretions around the cuff and thereby reduce the risk of VAP. The
      investigators are planning a phase III, randomized, controlled trial comparing the
      effectiveness of a polyurethane-cuffed endotracheal tube (PUC-ETT), a polyurethane-cuffed
      tube that also allows continuous aspiration of subglottic secretions (PUC-CASS-ETT), and a
      conventional, polyvinylchloride-cuffed endotracheal tube (PVC-ETT) in mechanically ventilated
      patients with respiratory failure. Prior to initiating the Phase III trial, a smaller pilot
      study is necessary in order to establish feasibility and to gather data on endpoints in order
      to establish enrollment rates and project sample size for the definitive trial. For the
      purposes of planning, a surrogate for VAP, bacterial colonization of the trachea will be
      assessed from daily quantitative cultures to allow estimation of effect size for the two
      study devices. VAP will be diagnosed using objective criteria, based on cultures from
      bronchoalveolar lavage. The safety profile of the tubes will be evaluated using a
      multi-faceted approach, including short-term objective measures of laryngeal dysfunction and
      long-term subjective and objective assessment of upper airway problems via phone interview
      post-hospital discharge, and recording of device-related adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Patients With Tracheal Bacterial Colonization</measure>
    <time_frame>Tracheal colonization by Day 4 or extubation</time_frame>
    <description>The percentage of patients with quantitative culture growth from tracheal aspirate specimens of &gt;1,000,000 CFU between Day 2 and Day 4 of tracheal intubation/mechanical ventilation. Percentage of patients will be compared between the three study arms.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">117</enrollment>
  <condition>Ventilator-acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>PVC ETT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polyvinylchloride cuff endotracheal tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PUC ETT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Polyurethane cuff endotracheal tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PUC-CASS ETT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Polyurethane cuff with continuous aspiration of subglottic secretions endotracheal tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PVC ETT</intervention_name>
    <description>Placement of a PVC-cuffed ETT in the setting of emergent intubation.</description>
    <arm_group_label>PVC ETT</arm_group_label>
    <other_name>Mallinckrodt Hi-Lo Oral/Nasal ETT Cuffed. Murphy Eye.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PUC ETT</intervention_name>
    <description>Placement of a PUC-cuffed ETT in the setting of emergent intubation.</description>
    <arm_group_label>PUC ETT</arm_group_label>
    <other_name>Mallinckrodt Seal Guard, oral/nasal ETT.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PUC-CASS ETT</intervention_name>
    <description>Placement of a PUC-cuffed in the setting of emergent intubation, followed by continuous aspiration of subglottic secretions for the duration of mechanical ventilation.</description>
    <arm_group_label>PUC-CASS ETT</arm_group_label>
    <other_name>Mallincrodt Evac Oral ETT, Seal Guard, Murphy Eye</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years or older;

          2. Emergency intubation with a study device either in the field by Medic One, (the
             Seattle Fire Department program that provides basic and advanced life support services
             to the city) or at HMC;

          3. Absence of out-of-hospital cardiac arrest;

          4. Absence of major burns, penetrating trauma or absence any major trauma with systolic
             blood pressure &lt; 90 mmHg at the time of tracheal intubation.

        Exclusion Criteria:

          1. Use of a non-study designated intubation device (such as nasal intubation,
             tracheostomy, intubation in the operating room, intubation outside the study network
             such as occurring in an outside hospital or by other emergency response providers);

          2. Patients with permanent tracheostomy;

          3. Federally protected populations: Children (age &lt;18 years), pregnant women, and
             prisoners.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miriam Treggiari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://depts.washington.edu/prevent</url>
    <description>UW ACCORN</description>
  </link>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2012</study_first_submitted>
  <study_first_submitted_qc>December 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2012</study_first_posted>
  <results_first_submitted>October 31, 2016</results_first_submitted>
  <results_first_submitted_qc>May 11, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 12, 2017</results_first_posted>
  <last_update_submitted>September 25, 2017</last_update_submitted>
  <last_update_submitted_qc>September 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Miriam Treggiari</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>pneumonia</keyword>
  <keyword>endotracheal intubation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients undergoing emergency tracheal intubation. EMS routed Harborview Medical Center (HMC) or patients who required emergent tracheal intubation while in HMC.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>PVC ETT</title>
          <description>Polyvinylchloride cuff endotracheal tube
PVC ETT: Placement of a PVC-cuffed ETT in the setting of emergent intubation.</description>
        </group>
        <group group_id="P2">
          <title>PUC ETT</title>
          <description>Polyurethane cuff endotracheal tube
PUC ETT: Placement of a PUC-cuffed ETT in the setting of emergent intubation.</description>
        </group>
        <group group_id="P3">
          <title>PUC-CASS ETT</title>
          <description>Polyurethane cuff with continuous aspiration of subglottic secretions endotracheal tube
PUC-CASS ETT: Placement of a PUC-cuffed in the setting of emergent intubation, followed by continuous aspiration of subglottic secretions for the duration of mechanical ventilation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="35"/>
                <participants group_id="P3" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="28"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No ICU Admit</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Routed to OSH</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Figures do not include inadvertent enrollments (IRB excluded, Not admitted to ICU or Routed to OSH)</population>
      <group_list>
        <group group_id="B1">
          <title>PVC ETT</title>
          <description>Polyvinylchloride cuff endotracheal tube
PVC ETT: Placement of a PVC-cuffed ETT in the setting of emergent intubation.</description>
        </group>
        <group group_id="B2">
          <title>PUC ETT</title>
          <description>Polyurethane cuff endotracheal tube
PUC ETT: Placement of a PUC-cuffed ETT in the setting of emergent intubation.</description>
        </group>
        <group group_id="B3">
          <title>PUC-CASS ETT</title>
          <description>Polyurethane cuff with continuous aspiration of subglottic secretions endotracheal tube
PUC-CASS ETT: Placement of a PUC-cuffed in the setting of emergent intubation, followed by continuous aspiration of subglottic secretions for the duration of mechanical ventilation.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="34"/>
            <count group_id="B4" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="75"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Patients With Tracheal Bacterial Colonization</title>
        <description>The percentage of patients with quantitative culture growth from tracheal aspirate specimens of &gt;1,000,000 CFU between Day 2 and Day 4 of tracheal intubation/mechanical ventilation. Percentage of patients will be compared between the three study arms.</description>
        <time_frame>Tracheal colonization by Day 4 or extubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PVC ETT</title>
            <description>Polyvinylchloride cuff endotracheal tube
PVC ETT: Placement of a PVC-cuffed ETT in the setting of emergent intubation.</description>
          </group>
          <group group_id="O2">
            <title>PUC ETT</title>
            <description>Polyurethane cuff endotracheal tube
PUC ETT: Placement of a PUC-cuffed ETT in the setting of emergent intubation.</description>
          </group>
          <group group_id="O3">
            <title>PUC-CASS ETT</title>
            <description>Polyurethane cuff with continuous aspiration of subglottic secretions endotracheal tube
PUC-CASS ETT: Placement of a PUC-cuffed in the setting of emergent intubation, followed by continuous aspiration of subglottic secretions for the duration of mechanical ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients With Tracheal Bacterial Colonization</title>
          <description>The percentage of patients with quantitative culture growth from tracheal aspirate specimens of &gt;1,000,000 CFU between Day 2 and Day 4 of tracheal intubation/mechanical ventilation. Percentage of patients will be compared between the three study arms.</description>
          <units>percentage of tracheal colonization</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 2 months after extubation</time_frame>
      <desc>Death or prolonged hospitalization related to ETT model</desc>
      <group_list>
        <group group_id="E1">
          <title>PVC ETT</title>
          <description>Polyvinylchloride cuff endotracheal tube
PVC ETT: Placement of a PVC-cuffed ETT in the setting of emergent intubation.</description>
        </group>
        <group group_id="E2">
          <title>PUC ETT</title>
          <description>Polyurethane cuff endotracheal tube
PUC ETT: Placement of a PUC-cuffed ETT in the setting of emergent intubation.</description>
        </group>
        <group group_id="E3">
          <title>PUC-CASS ETT</title>
          <description>Polyurethane cuff with continuous aspiration of subglottic secretions endotracheal tube
PUC-CASS ETT: Placement of a PUC-cuffed in the setting of emergent intubation, followed by continuous aspiration of subglottic secretions for the duration of mechanical ventilation.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Death from any cause</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="36"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="32"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Up to 2 months after extubation airway complications</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Miriam Treggiari</name_or_title>
      <organization>Oregon Health Science &amp; Science University</organization>
      <phone>(503) 494-8311</phone>
      <email>treggiar@ohsu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

